DXCM
DexCom, Inc. · Healthcare · Medical - Devices
动量输入(同类管理人):
持有人广度 +5.0% ·
股份流向 -3.1% ·
净新建仓位 +4.8%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q4 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 360.94K | $29.46M | n/a | −1 |
| Q2 2026 | 168 | +1 | 305.13M | $20.51B | +7 | −5 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | n/a |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | n/a | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | n/a | n/a |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | n/a |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | n/a | −2 |
| Q2 2024 | 21 | n/a | 52.99M | $6.01B | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 16.69M | n/a | $1.30B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 14.61M | -2.7% | $1.14B | 0.9% | ▼ Trim | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (被动) | 9.99M | +0.6% | $775.26M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 4.96M | -1.0% | $385.37M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 4.26M | +245.4% | $331.41M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Capital World Investors ✦ | 3.84M | -49.6% | $298.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 3.53M | +45.3% | $274.54M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 3.08M | +800.3% | $239.22M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 1.94M | -39.7% | $150.84M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 1.60M | 新增 | $124.34M | 0.3% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 889.87K | +7.1% | $69.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 863.02K | +4.6% | $67.12M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Fisher Asset Management ✦ | 761.84K | -11.0% | $59.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 608.21K | +208.3% | $47.30M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 15 | Adage Capital Partners ✦ | 555.12K | +1.3% | $43.17M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 539.29K | +104.3% | $41.94M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 17 | Gotham Asset Management ✦ | 114.68K | +45.5% | $8.92M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 97.94K | -69.4% | $7.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 54.83K | -32.7% | $4.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 52.00K | 0.0% | $4.04M | 0.0% | Held | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 25.84K | -99.5% | $2.01M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $124.34M | 0.3% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 1 持有人, 15.50K 股份, $973 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 2.56K 股 · $220,975
Director · 6.54K 股 · $549,538
Officer · 1.70K 股 · $142,868
Director · 1.55K 股 · $130,231
Officer · 3.64K 股 · $302,936
Officer · 2.56K 股 · $226,669
Officer, Director · 19.31K 股 · $1.73M
Officer, Director · 97 股 · $8,867
Officer, Director · 7.35K 股 · $667,332
Officer · 1.70K 股 · $156,281
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论